Announcements Trials
Browse Landscape Eligibility

Clinical Trials

81,972 trials
RecentStart dateEnrollment
OTHER × Clear all

Phase

Phase NA 23012Phase 2 19564Phase 1 6816Phase 3 4223Phase 1/2 4127Phase 4 1847Phase EARLY_PHASE1 1576Phase 2/3 956

Status

Completed 32698Unknown 15066Recruiting 14085Terminated 6334Active not recruiting 5025Not yet recruiting 4834Withdrawn 2933Enrolling by invitation 571Suspended 313No longer available 66Available 29Approved for marketing 15Temporarily not available 3

Sponsor Class

OTHER 81972INDUSTRY 26665NIH 5179NETWORK 2562OTHER_GOV 2412FED 276UNKNOWN 266INDIV 54

Study Type

Interventional 62122Observational 19737Expanded_access 113

Sponsor

Cancer Type

Gastrointestinal 17289Breast 10900Genitourinary 7747Thoracic 7550Lymphoid 6518Other hematologic neoplasm 6125Gynecologic 4765Head & Neck 4641CNS 4335Tumor-Agnostic 2944Dermatologic 2740Plasma cell 2388Sarcoma 2205Myeloid 1731Other solid neoplasm 1343Endocrine 1260Other 738Classical hematology 717NET 427Other neoplasm 255

Conditions

Breast Neoplasms 9355Neoplasms 6502Prostatic Neoplasms 4354Colorectal Neoplasms 3920Lung Neoplasms 3586Carcinoma, Non-Small-Cell Lung 3538Pancreatic Neoplasms 2441Carcinoma, Hepatocellular 2373Leukemia, Myeloid, Acute 2230Multiple Myeloma 2098Stomach Neoplasms 2075Neoplasm Metastasis 1897Head and Neck Neoplasms 1846Ovarian Neoplasms 1756Precursor Cell Lymphoblastic Leukemia-Lymphoma 1724Lymphoma 1720Brain Neoplasms 1687Rectal Neoplasms 1657Melanoma 1641Colonic Neoplasms 1619Leukemia 1496Uterine Cervical Neoplasms 1473Recurrence 1465Esophageal Neoplasms 1299Glioblastoma 1285Lymphoma, Non-Hodgkin 1199Leukemia, Lymphocytic, Chronic, B-Cell 1117Squamous Cell Carcinoma of Head and Neck 1091Urinary Bladder Neoplasms 1066Lymphoma, Follicular 1056

Interventions

Cyclophosphamide 2053Radiotherapy 1972Cisplatin 1837Carboplatin 1551Gemcitabine 1443Paclitaxel 1315Bevacizumab 1305pembrolizumab 1231Docetaxel 1224Oxaliplatin 1172Capecitabine 1164Fluorouracil 1078Dexamethasone 972Magnetic Resonance Spectroscopy 952Nivolumab 932Rituximab 923Drug Therapy 899Surveys and Questionnaires 891Doxorubicin 844Etoposide 839Radiosurgery 807Blood Specimen Collection 806Irinotecan 782Cytarabine 738fludarabine 710Leucovorin 679Surgical Procedures, Operative 632Lenalidomide 616Biopsy 582fludarabine phosphate 565

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT00466531 2026-04-16

Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
50 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00479128 2026-04-16

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
80 enrolled
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00539162 2026-04-16

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

M.D. Anderson Cancer Center

Phase NA Recruiting
8,000 enrolled
Gynecologic

Ovarian Neoplasms

NCT00567684 2026-04-16

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

M.D. Anderson Cancer Center

Phase NA Active not recruiting
133 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT00761618 2026-04-16

Intrapleural Catheter Daily Versus Three Times a Week Drainage

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
257 enrolled
Thoracic

Pleural Effusion, Pleural Effusion, Malignant

NCT00816114 2026-04-16

Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

M.D. Anderson Cancer Center

Recruiting
3,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01057953 2026-04-16

DOCC

University Hospital, Rouen

Phase NA Completed
1,550 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT01187199 2026-04-16

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
278 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01266044 2026-04-16

Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
435 enrolled
Head & Neck

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Xerostomia

NCT01590069 2026-04-16

Aerosolized Aldesleukin in Treating Patients With Lung Metastases

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
70 enrolled
DermatologicGenitourinarySarcoma

Carcinoma, Renal Cell, Melanoma, Sarcoma, Osteosarcoma

NCT01627093 2026-04-16

Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy

M.D. Anderson Cancer Center

Active not recruiting
450 enrolled
Head & Neck

Head and Neck Carcinoma

NCT01709292 2026-04-16

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
24 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

NCT01907789 2026-04-16

Prophylactic Salpingectomy With Delayed Oophorectomy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
80 enrolled
Gynecologic

Ovarian Neoplasms

NCT01931579 2026-04-16

NODIVEM

University Hospital, Rouen

Phase NA Completed
120 enrolled

Respiratory Tract Neoplasms

NCT02110329 2026-04-16

Code Barre

University Hospital, Rouen

Phase NA Completed
401 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02128906 2026-04-16

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

University of Pittsburgh

Phase 2 Recruiting
120 enrolled
Head & Neck

Carcinoma, Squamous Cell, Laryngeal Diseases

NCT02131584 2026-04-16

Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
10 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02468024 2026-04-16

STABLE-MATES

University of Texas Southwestern Medical Center

Phase 3 Recruiting
272 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02543320 2026-04-16

Neurofeedback in Decreasing Acute Radiotherapy-Induced Pain in Patients With Head and Neck Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
17 enrolled
Head & Neck

Head and Neck Carcinoma

NCT02557061 2026-04-16

TIL

University Hospital, Rouen

Phase NA Completed
56 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02615275 2026-04-16

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
50 enrolled
Head & Neck

Head and Neck Carcinoma

NCT02626312 2026-04-16

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
36 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT02645487 2026-04-16

SRS

University of Texas Southwestern Medical Center

Phase NA Active not recruiting
135 enrolled
CNS

Brain Neoplasms

NCT02662907 2026-04-16

Cough, Expiratory Training, and Chronic Aspiration After Head and Neck Radiotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
175 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02726750 2026-04-16

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

M.D. Anderson Cancer Center

Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

NCT02744053 2026-04-16

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
96 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02816697 2026-04-16

Implementation of a System-level Tobacco Treatment Intervention

Dana-Farber Cancer Institute

Phase NA Completed
263 enrolled
Thoracic

Lung Neoplasms, Smoking, Smoking Cessation

NCT02863107 2026-04-16

Young-Onset Colorectal Cancer

M.D. Anderson Cancer Center

Active not recruiting
818 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02872779 2026-04-16

COCA-MACS

University Hospital, Rouen

Phase NA Completed
74 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02911064 2026-04-16

Expectations Regarding Mobility and Self-Care

M.D. Anderson Cancer Center

Active not recruiting
133 enrolled
Tumor-Agnostic

Neoplasms

NCT02918474 2026-04-16

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

M.D. Anderson Cancer Center

Phase NA Recruiting
15 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT03048279 2026-04-16

Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

M.D. Anderson Cancer Center

Active not recruiting
1,500 enrolled
Endocrine

Multiple Endocrine Neoplasia

NCT03110978 2026-04-16

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
140 enrolled
EndocrineThoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Neuroendocrine

NCT03122197 2026-04-16

Study of Letrozole in Recurrent Gliomas

University of Cincinnati

Phase EARLY_PHASE1 Recruiting
39 enrolled
CNS

Brain Neoplasms

NCT03133650 2026-04-16

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Esophagogastric Cancer

NCT03145077 2026-04-16

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

M.D. Anderson Cancer Center

Phase NA Recruiting
1,400 enrolled
Head & Neck

Head and Neck Neoplasms, Osteoradionecrosis

NCT03377387 2026-04-16

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
34 enrolled
Breast

Breast Neoplasms

NCT03418038 2026-04-16

Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

Mayo Clinic

Phase 2 Recruiting
80 enrolled
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse

NCT03435952 2026-04-16

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
18 enrolled
BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT03574792 2026-04-16

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Roswell Park Cancer Institute

Phase 2 Completed
62 enrolled 10 charts
DermatologicHead & Neck

Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8

NCT03618550 2026-04-16

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
257 enrolled
Lymphoid

Hodgkin Disease, Recurrence

NCT03620786 2026-04-16

HIFU for Focal Ablation of Prostate Tissue: An Observational Study

University of California, Los Angeles

Recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT03634241 2026-04-16

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

M.D. Anderson Cancer Center

Phase 2 Completed
45 enrolled 9 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03922555 2026-04-16

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Massachusetts General Hospital

Phase 1 Recruiting
18 enrolled
CNS

Central Nervous System Neoplasms

NCT04003038 2026-04-16

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

M.D. Anderson Cancer Center

Phase NA Recruiting
80 enrolled
BreastOther

Breast Neoplasms, Obesity

NCT04085276 2026-04-16

TORCHLIGHT

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
531 enrolled
Breast

Triple Negative Breast Neoplasms

NCT04125914 2026-04-16

Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families

M.D. Anderson Cancer Center

Phase NA Active not recruiting
384 enrolled
BreastGastrointestinal

Breast Cancer, Familial, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT04140487 2026-04-16

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

M.D. Anderson Cancer Center

Phase 1/2 Recruiting
97 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases

NCT04189757 2026-04-16

Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
9 enrolled
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡